Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiu Sun

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Acta Pharmacologica Sinica|September 22, 2007
Organic anion transporting polypeptide-1B1 haplotypes in Chinese patientsLin-Yong Xu, Yi-Jing He, Wei Zhang, et al.
Ecotoxicology and Environmental Safety|August 17, 2025
Chemical carcinogenicity of neodymium nitrate in AML12 hepatocytes: Dose-response metabolomics and sensitive biomarker identificationNing Wang, Da-Sheng Lu, Jing Leng, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 25, 2023
Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumabShenglin Li, Long Yuan, Mengying Yue, et al.
Journal of Medicinal Chemistry|November 28, 2018
Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis ModelYueshan Li, Yu Xiong, Guo Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2025
Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacyQiu Sun, Xiaowen Tian, Lun Tan, et al.
Journal of Medicinal Chemistry|March 8, 2019
Correction to Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis ModelYueshan Li, Yu Xiong, Guo Zhang, et al.
Signal Transduction and Targeted Therapy|June 1, 2019
Deciphering the regulatory and catalytic mechanisms of an unusual SAM-dependent enzymeQiu Sun, Yuehong Hu, Yijun Gu, et al.
ACS Nano|December 30, 2014
Transfer-free synthesis of doped and patterned graphene filmsQi-Qi Zhuo, Qi Wang, Yi-Ping Zhang, et al.
Cell Research|September 30, 2017
Structural and mechanistic insights into the biosynthesis of CDP-archaeol in membranesSixue Ren, Antonella Caforio, Qin Yang, et al.
Nature Communications|November 29, 2025
Avian GCGR-mediated continuous fat utilization offers perspectives for obesity treatmentChang Zhang, Xue Wang, Chenxi Feng, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Acta Pharmacologica Sinica|September 22, 2007
Organic anion transporting polypeptide-1B1 haplotypes in Chinese patientsLin-Yong Xu, Yi-Jing He, Wei Zhang, et al.
Ecotoxicology and Environmental Safety|August 17, 2025
Chemical carcinogenicity of neodymium nitrate in AML12 hepatocytes: Dose-response metabolomics and sensitive biomarker identificationNing Wang, Da-Sheng Lu, Jing Leng, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 25, 2023
Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumabShenglin Li, Long Yuan, Mengying Yue, et al.
Journal of Medicinal Chemistry|November 28, 2018
Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis ModelYueshan Li, Yu Xiong, Guo Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2025
Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacyQiu Sun, Xiaowen Tian, Lun Tan, et al.
Journal of Medicinal Chemistry|March 8, 2019
Correction to Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis ModelYueshan Li, Yu Xiong, Guo Zhang, et al.
Signal Transduction and Targeted Therapy|June 1, 2019
Deciphering the regulatory and catalytic mechanisms of an unusual SAM-dependent enzymeQiu Sun, Yuehong Hu, Yijun Gu, et al.
ACS Nano|December 30, 2014
Transfer-free synthesis of doped and patterned graphene filmsQi-Qi Zhuo, Qi Wang, Yi-Ping Zhang, et al.
Cell Research|September 30, 2017
Structural and mechanistic insights into the biosynthesis of CDP-archaeol in membranesSixue Ren, Antonella Caforio, Qin Yang, et al.
Nature Communications|November 29, 2025
Avian GCGR-mediated continuous fat utilization offers perspectives for obesity treatmentChang Zhang, Xue Wang, Chenxi Feng, et al.
Pageof 23